Security Snapshot

BIO-TECHNE Corp - Common Stock (TECH) Institutional Ownership

CUSIP: 09073M104

13F Institutional Holders and Ownership History from Q3 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

577

Shares (Excl. Options)

171,842,688

Price

$58.81

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
TECH on Nasdaq
Shares outstanding
152,309,909
Price per share
$52.26
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
171,842,688
Total reported value
$10,108,159,260
% of total 13F portfolios
0.01%
Share change
+10,877,241
Value change
+$654,037,854
Number of holders
577
Price from insider filings
$52.26
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • TECH - BIO-TECHNE Corp - Common Stock is tracked under CUSIP 09073M104.
  • 577 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 577 to 102 between Q4 2025 and Q1 2026.
  • Reported value moved from $10,108,159,260 to $140,643,807.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 577 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 09073M104?
CUSIP 09073M104 identifies TECH - BIO-TECHNE Corp - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of BIO-TECHNE Corp - Common Stock (TECH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7% $566,544,556 11,011,556 BlackRock, Inc. 30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% -57% $186,406,005 -$305,816,579 3,350,818 -62% T. Rowe Price Associates, Inc. 30 Sep 2025

As of 31 Dec 2025, 577 institutional investors reported holding 171,842,688 shares of BIO-TECHNE Corp - Common Stock (TECH). This represents 113% of the company’s total 152,309,909 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BIO-TECHNE Corp - Common Stock (TECH) together control 70% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 17,810,878 -0.68% 0.02% $1,047,457,735
BlackRock, Inc. 8% 12,129,125 +2% 0.01% $713,313,819
MORGAN STANLEY 5.5% 8,345,414 +15% 0.03% $490,794,044
STATE STREET CORP 3.8% 5,812,032 +1% 0.01% $341,805,602
WELLINGTON MANAGEMENT GROUP LLP 3.8% 5,734,049 +12% 0.06% $337,219,422
GEODE CAPITAL MANAGEMENT, LLC 3.2% 4,929,801 +0.05% 0.02% $289,502,286
PRICE T ROWE ASSOCIATES INC /MD/ 2.7% 4,075,194 +22% 0.03% $239,663,000
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.6% 4,012,818 +164% 0.08% $235,993,825
MAVERICK CAPITAL LTD 2.5% 3,850,923 +28% 2.4% $226,472,782
Invesco Ltd. 2.4% 3,678,659 -6.8% 0.03% $216,341,937
NEUBERGER BERMAN GROUP LLC 2.1% 3,129,334 -5.4% 0.14% $184,036,113
Select Equity Group, L.P. 1.9% 2,837,142 +26% 0.77% $166,852,321
AMERIPRISE FINANCIAL INC 1.8% 2,798,437 -0.59% 0.04% $164,576,211
MAIRS & POWER INC 1.8% 2,767,539 -1.4% 1.6% $162,758,957
DF DENT & CO INC 1.7% 2,592,215 -6.8% 2.2% $152,448,149
MACKENZIE FINANCIAL CORP 1.6% 2,414,165 -5.7% 0.17% $142,444,643
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.6% 2,398,265 +40% 0.39% $141,041,965
Sumitomo Mitsui Trust Group, Inc. 1.6% 2,368,162 +0.53% 0.08% $139,271,607
ALLIANCEBERNSTEIN L.P. 1.6% 2,364,845 +158% 0.04% $139,076,534
UBS Group AG 1.5% 2,224,263 +47% 0.03% $130,808,907
RGM Capital, LLC 1.4% 2,152,052 -6.4% 6.1% $126,562,178
Durable Capital Partners LP 1.4% 2,088,891 +50% 1.2% $122,847,680
AMERICAN CENTURY COMPANIES INC 1.3% 1,928,485 -5.4% 0.06% $113,414,203
SNYDER CAPITAL MANAGEMENT L P 1.3% 1,926,866 +12% 2.1% $113,318,989
DIMENSIONAL FUND ADVISORS LP 1.2% 1,794,293 +4.9% 0.02% $105,523,778

Institutional Holders of BIO-TECHNE Corp - Common Stock (TECH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 2,688,670 $140,643,807 -$23,585,089 $52.26 102
2025 Q4 171,842,688 $10,108,159,260 +$654,037,854 $58.81 577
2025 Q3 158,850,861 $8,835,899,945 +$43,569,058 $55.63 569
2025 Q2 158,628,992 $8,162,083,726 -$121,661,613 $51.45 549
2025 Q1 160,482,754 $9,405,648,682 +$179,026,718 $58.63 570
2024 Q4 156,683,809 $11,287,230,171 +$66,773,071 $72.03 570
2024 Q3 154,600,456 $12,351,604,330 +$7,433,196 $79.93 556
2024 Q2 155,869,664 $11,167,617,679 -$177,733,977 $71.65 567
2024 Q1 158,523,717 $11,156,213,905 +$202,103,671 $70.39 546
2023 Q4 155,453,274 $11,990,770,023 +$252,157,462 $77.16 525
2023 Q3 152,193,816 $10,358,362,931 +$40,449,398 $68.07 522
2023 Q2 151,139,522 $12,331,718,195 +$212,796,041 $81.63 521
2023 Q1 148,715,946 $11,031,044,107 -$125,004,989 $74.19 542
2022 Q4 150,382,048 $12,465,020,754 +$9,251,047,940 $82.88 536
2022 Q3 38,142,242 $10,837,756,102 +$194,266,932 $284.00 520
2022 Q2 37,209,172 $12,897,621,890 -$179,595,754 $346.64 534
2022 Q1 37,711,486 $16,331,488,594 +$324,651,170 $433.04 546
2021 Q4 36,855,059 $19,055,177,448 -$21,586,911 $517.34 560
2021 Q3 36,736,696 $17,797,604,388 +$72,229,932 $484.57 556
2021 Q2 36,589,162 $16,468,259,256 +$203,566,288 $450.26 504
2021 Q1 36,496,866 $13,940,028,921 +$172,769,577 $381.93 460
2020 Q4 36,189,306 $11,493,926,712 -$16,778,721 $317.55 426
2020 Q3 36,254,970 $8,982,485,029 -$42,929,390 $247.73 409
2020 Q2 36,379,136 $9,604,991,764 -$81,539,071 $264.07 384
2020 Q1 36,823,671 $6,987,799,245 +$119,012,127 $189.62 357
2019 Q4 35,776,726 $7,852,981,745 -$46,029,404 $219.51 366
2019 Q3 35,990,901 $7,043,547,397 +$117,132,644 $195.67 333
2019 Q2 35,416,061 $7,383,307,878 +$61,945,595 $208.49 362
2019 Q1 35,546,314 $7,057,725,860 +$61,379,403 $198.55 347
2018 Q4 35,371,213 $5,119,061,152 -$122,869,763 $144.72 316
2018 Q3 35,826,309 $7,311,255,210 +$15,680,998 $204.11 335
2018 Q2 35,998,975 $5,325,911,858 +$35,737,877 $147.95 333
2018 Q1 35,891,582 $5,420,812,522 -$28,478,791 $151.04 325
2017 Q4 36,357,570 $4,710,259,737 -$46,673,008 $129.55 288
2017 Q3 36,860,326 $4,455,237,647 -$52,528,460 $120.89 282
2017 Q2 37,300,606 $4,382,632,640 +$214,841,252 $117.50 272
2017 Q1 36,529,302 $3,713,044,239 +$392,401,939 $101.65 265
2016 Q4 35,943,908 $3,695,994,947 +$12,675,458 $102.83 270
2016 Q3 35,799,364 $3,917,777,202 -$132,633,733 $109.50 279
2016 Q2 37,060,472 $4,178,830,306 -$54,302,334 $112.77 278
2016 Q1 37,564,549 $3,550,310,945 +$20,269,808 $94.52 251
2015 Q4 37,359,133 $3,362,530,330 +$85,876,184 $90.00 258
2015 Q3 36,302,435 $3,356,422,402 -$28,590,696 $92.46 245
2015 Q2 36,725,188 $3,616,194,794 +$4,045,129 $98.47 238
2015 Q1 36,495,519 $3,659,215,883 +$67,728,039 $100.29 243
2014 Q4 36,050,484 $3,331,456,988 +$2,869,117,238 $92.40 252
2014 Q3 4,950,723 $463,140,000 +$463,140,000 $93.55 24